首页|期刊导航|中国神经再生研究（英文版）|Dysregulation of RNA modification systems in clinical populations with neurocognitive disorders

Dysregulation of RNA modification systems in clinical populations with neurocognitive disorders

Helen M.Knight Merve Demirbugen Öz Adriana PerezGrovas-Saltijeral

中国神经再生研究（英文版）2024，Vol.19Issue(6)：1256-1261,6.

中国神经再生研究（英文版）2024，Vol.19Issue(6)：1256-1261,6.DOI:10.4103/1673-5374.385858

Dysregulation of RNA modification systems in clinical populations with neurocognitive disorders

Helen M.Knight ¹Merve Demirbugen Öz ²Adriana PerezGrovas-Saltijeral¹

作者信息

1. Division of Cells,Organisms and Molecular Genetics,School of Life Sciences,University of Nottingham,Nottingham,UK
2. Department of Pharmaceutical Toxicology,Faculty of Pharmacy,Ankara University,Ankara,Turkey
折叠

摘要

关键词

5-methylcytosine methylation/Alzheimer's disease/cognitive diseases/epitranscriptomics/intellectual disability/Lewy body diseases/N6 adenosine/RNA modification

Key words

5-methylcytosine methylation/Alzheimer's disease/cognitive diseases/epitranscriptomics/intellectual disability/Lewy body diseases/N6 adenosine/RNA modification

引用本文复制引用

Helen M.Knight,Merve Demirbugen Öz,Adriana PerezGrovas-Saltijeral..Dysregulation of RNA modification systems in clinical populations with neurocognitive disorders[J].中国神经再生研究（英文版）,2024,19(6):1256-1261,6.

基金项目

This work was funded by Nottingham University and the Neuroscience Support Group Charity,UK(to HMK).APS was supported by a CONACYT PhD scholarship.MDÖ was supported by the Postdoctoral Research Fellowship Program of TUBITAK. （to HMK）

中国神经再生研究（英文版）

OACSTPCD

ISSN：1673-5374

访问量1

下载量0

段落导航